The Foundry :: Investors

Home / Who We Are / Investors

One important reason The Foundry is such a valuable partner is its strong financial backing and close relationships with experienced entrepreneurs and investors in the medical device community. The Foundry companies receive their initial funding from Domain Associates, Morgenthaler Ventures and Versant Ventures. In addition, The Foundry has helped raise over $500 million for our portfolio companies in various stages of financings from such notable venture capital firms as:

– ABS Ventures
– Advanced Technology Ventures
– Aisling Capital
– BBT Fund LP
– Bluebird Development, LLC
– Canaan
– Cargill Ventures
– Cross Creek Advisors
– Cutlass Capital
– Delphi Ventures
– Domain Associates
– Finisterre
– Emergent Medical Ventures
– Frazier Healthcare Ventures
– H & Q Capital Management
– HLM Venture Partners
– Integral Capital Partners
– Investor Growth Capital
– Kaiser Permanente

– Latterell Venture Partners
– Lightstone Ventures
– Morgan Stanley
– Morgenthaler Ventures
– New Enterprise Associates
– New Venture Partners
– Neuroventures
– OrbiMed Advisors
– Oxford Bioscience Partners
– Pinnacle Ventures
– Proquest
– Prospect Ventures
– Schroder Ventures Life Sciences
– Skyline Ventures
– Technology Partners
– Three Arch Partners
– Venrock Associates
– Versant Ventures